DPP4 and neoplasm: Although the exact nature of the CD26 and CD9 association was not elucidated in the report, our current data clearly demonstrate that CD26+CD9+ cells exhibit higher invasive activity than CD26−CD9+ cells, suggesting that CD26 may potentiate tumor cell invasiveness.